Poli Mara Spritzer
Overview
Explore the profile of Poli Mara Spritzer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
1354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Benham J, Corbett K, Yamamoto J, McClurg C, Piltonen T, Yildiz B, et al.
Obes Rev
. 2024 Mar;
25(6):e13737.
PMID: 38491863
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in females. Modest weight loss improves reproductive and metabolic PCOS features. While lifestyle modifications and pharmacotherapies remain first-line weight loss strategies,...
12.
Fitz V, Graca S, Mahalingaiah S, Liu J, Lai L, Butt A, et al.
J Clin Endocrinol Metab
. 2024 Jan;
109(6):1630-1655.
PMID: 38163998
Context: Insulin resistance is common in women with polycystic ovary syndrome (PCOS). Inositol may have insulin sensitizing effects; however, its efficacy in the management of PCOS remains indeterminate. Objective: To...
13.
Castro S, Wiest P, Spritzer P, Kopacek C
Endocr Connect
. 2023 Oct;
12(12).
PMID: 37902057
Congenital adrenal hyperplasia (CAH) occurs due to enzyme defects in adrenal steroidogenesis. The 21-hydroxylase deficiency accounts for 90-95% of cases, triggering accumulation of 17-hydroxyprogesterone (17-OHP). Early diagnosis through neonatal screening...
14.
Fighera T, Dos Santos B, Spritzer P
PLoS One
. 2023 Oct;
18(10):e0292623.
PMID: 37796920
Although current evidence suggests increased risk of obesity, insulin resistance, and metabolic alterations in patients with polycystic ovary syndrome (PCOS), especially of a hyperandrogenic phenotype, the impact of each one...
15.
Leal C, Zanolla K, Spritzer P, Reis F
Endocr Pract
. 2023 Sep;
30(1):64-69.
PMID: 37708997
Objective: In this narrative review, we discuss the current evidence as well as the knowledge gaps concerning assisted reproductive technology (ART) indications, protocols, and results in the presence of polycystic...
16.
Melin J, Forslund M, Alesi S, Piltonen T, Romualdi D, Spritzer P, et al.
J Clin Endocrinol Metab
. 2023 Aug;
109(2):e817-e836.
PMID: 37554096
Context: Polycystic ovary syndrome (PCOS) affects more than 1 in 10 women. Objective: As part of the 2023 International PCOS Guidelines update, comparisons between combined oral contraceptive pills (COCP), metformin,...
17.
Melin J, Forslund M, Alesi S, Piltonen T, Romualdi D, Spritzer P, et al.
Eur J Endocrinol
. 2023 Aug;
189(2):S37-S63.
PMID: 37536294
Objective: Available evidence has shown that metformin improves insulin sensitivity and weight management in polycystic ovary syndrome (PCOS). Nevertheless, key knowledge gaps remain regarding its efficacy and the specific outcomes...
18.
Schwarz K, Cielo C, Spritzer P, Villas-Boas A, Costa A, Fontanari A, et al.
Syst Rev
. 2023 Jul;
12(1):128.
PMID: 37481572
Background: We systematically reviewed the literature and performed a meta-analysis on the effects of speech therapy and phonosurgery, for transgender women, in relation to the fundamental frequency gain of the...
19.
Fighera T, Santos B, Motta L, Casanova G, Spritzer P
Menopause
. 2023 Feb;
30(3):317-322.
PMID: 36729603
Objectives: The aim of this study was to explore body composition parameters and hormone levels as risk factors for low bone mass (osteopenia/osteoporosis) in postmenopausal women. Methods: We analyzed biorepository...
20.
Moreira Allgayer R, Borba G, Moraes R, Ramos R, Spritzer P
Endocr Pract
. 2023 Jan;
29(6):498-507.
PMID: 36603652
Objective: The impact of gender-affirming hormone therapy (GAHT) on cardiovascular (CV) health is still not entirely established. A systematic review was conducted to summarize the evidence on the risk of...